Livzon Pharmaceutical Group 丽珠集团
3 significant filings since 29 May 2026: 2 on guarantee or financial assistance and 1 on dividend. The latest, on 5 Sep 2026: 关于为子公司提供担保的进展公告.
自 29 May 2026 起有 3 份重大公告：guarantee or financial assistance 2 份、dividend 1 份。最新一份（5 Sep 2026）：关于为子公司提供担保的进展公告。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 2 brokers | 2 brokers |
| 7 days ago | 2 brokers | 2 brokers |
| 30 days ago | 0 brokers | 0 brokers |
| 60 days ago | 2.41 | 2.64 |
| 90 days ago | 2.39 | 2.64 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 3.01 in Sep 2024 to 2.41 in Jul 2026 (-19.9%). 一致预期从 Sep 2024 的 3.01 变为 Jul 2026 的 2.41 (-19.9%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 1 = 1 | ▲ 0 ▼ 1 = 1 |
| Last 90 days | ▲ 0 ▼ 1 = 1 | ▲ 0 ▼ 1 = 1 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0.